VASAMED, Inc.
VSMD
$0.00
$0.000.00%
| 06/30/2009 | 03/31/2009 | 12/31/2008 | 09/30/2008 | 06/30/2008 | |
|---|---|---|---|---|---|
| Revenue | 689.90K | 968.50K | 960.60K | 813.70K | 743.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 689.90K | 968.50K | 960.60K | 813.70K | 743.00K |
| Cost of Revenue | 374.50K | 414.70K | 287.10K | 374.40K | 396.30K |
| Gross Profit | 315.40K | 553.80K | 673.50K | 439.30K | 346.70K |
| SG&A Expenses | 517.10K | 538.60K | 593.70K | 685.90K | 744.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.14M | 1.30M | 1.20M | 1.42M | 1.51M |
| Operating Income | -446.10K | -327.50K | -243.20K | -604.90K | -769.00K |
| Income Before Tax | -523.70K | -410.60K | -331.70K | -662.00K | -806.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -523.70K | -410.60K | -331.70K | -662.00K | -806.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -523.70K | -410.60K | -331.70K | -662.00K | -806.40K |
| EBIT | -446.10K | -327.50K | -243.20K | -604.90K | -769.00K |
| EBITDA | -419.60K | -290.30K | -200.90K | -563.50K | -726.30K |
| EPS Basic | -0.07 | -0.05 | -0.04 | -0.08 | -0.10 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.03 | -0.05 | -0.06 |
| EPS Diluted | -0.07 | -0.05 | -0.04 | -0.08 | -0.10 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.03 | -0.05 | -0.06 |
| Average Basic Shares Outstanding | 8.01M | 8.01M | 8.01M | 8.01M | 8.01M |
| Average Diluted Shares Outstanding | 8.01M | 8.01M | 8.01M | 8.01M | 8.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
